Laboratory benchmarking: more efficiency and productivity in the routine

bench

From the analysis of benchmarking data, it is possible to outline strategies to boost services and generate better opportunities for the laboratory.

Laboratories were already being challenged for some years to optimize their processes to generate better operating and financial results in the face of the transformations in the segment. However, in 2020, due to the Covid-19 pandemic, these challenges became even more complex with the social and economic impacts resulting from the disease.

Planning the development and growth of the laboratory requires realistic goals and monitoring, updated with market practices and performance. These consistent goals enable investment in actions that really make the laboratory strategically competitive. The most solid way to obtain this guiding information, which will be even more valuable in post-pandemic resumption, is using benchmarking.

Laboratory Benchmarking is an analysis of comparison of results between laboratories against the standards of excellence of the market. By using it, the laboratory improves its processes, improves services and generates more productivity and opportunities for the organization.

By participating in benchmarking programs, the laboratory optimizes time and resources in search of market information. For the user to understand in practice the benefits of the tool, figures 1 and 2, highlighted below, illustrate how benchmarking optimizes the organization’s efforts:

benchmarking na pratica img01 destaques 20201117 en 1

Figure 1 represents the case of laboratory X that established goals (orange line) to increase its productivity. The results (blue columns) show that, in the first months, the target was exceeded, being adjusted from June. Lab X sought to achieve this new goal, reaching it near the third quarter.

A first look at these results may indicate that the investments made and the goals achieved are leading to the planned objective. However, how to know if the goal defined by the laboratory is aligned with the competitive market scenario? Is this performance similar to that practiced by other laboratories with similar profiles? Figure 2 helps to answer these questions.

benchmarking na pratica img02 destaques 20201117 en

Figure 2 refers to the productivity benchmarking carried out between laboratories with profiles similar to laboratory X. The boxplot graph clearly shows how the data of these participants behaved. The black line, in bold in the graph, represents the productivity results achieved by 50% of its peers (institutions with the same profile as laboratory X).

When transporting the target (orange line) and the results (red dots) from laboratory X to benchmarking, we identified that although productivity presents a favorable behavior – meeting the initial expectations of laboratory X – it is still not enough to guarantee competitiveness of laboratory X opposite to the market.

Benchmarking enables laboratories to make assertive decisions, enabling continuous and up-to-date access to market data, guaranteeing references that are always in line with standards of excellence.

Delivering information to assess the organization in relation to the market and improve results are some of the objectives of the Benchmarking and Laboratory Indicator Program (PBIL), conducted by Controllab in partnership with the Brazilian Society of Clinical Pathology/Laboratory Medicine.

Through the data provided by the program, the laboratory can invest in actions that make it strategically competitive. This marketing vision contributes to reducing inefficient efforts and increasing the effectiveness of operations, optimizing the organization’s technical and financial resources.

The benefits of participating in the program, which helped to cope with the difficulties generated by the beginning of the pandemic, were evidenced in a recent congress of the segment. With the program, managers were able to make agile and data-based decisions, assess the efficiency of emergency actions and continue to monitor the performance of their business.

If before the scenario was already challenging for laboratories, with the current and future impacts of the pandemic, knowing the weaknesses and strengths of the laboratory are determining factors for the decisions of the coming months.

More information about PBIL and other Controllab solutions can be found on the website, pelo e-mail contato@controllab.com or by phone and WhatsApp +55 (21) 97901-0310 and +55 (21) 98036-1592.

Sign up for our newsletter

Receive relevant publications about labs, solutions for quality
management and optimization of business management.

LOG IN

acesso ao sitema

Estamos enfrentando alguns problemas de acesso ao sistema, pedimos a compreensão de todos. Tente novamente em alguns minutos.

COOKIES NOTICE

We use cookies and other similar technologies to improve your experience, enabling a more personalized navigation, according to the characteristics and your interest.

For more information see our Privacy and Security Policy.

PRM 0009

Accreditation Cgcre/Inmetro - Certified Reference Material Producer

Controllab has been accredited as a Certified Reference Material Producer (MRC) since 2016 by Inmetro’s General Coordination for Accreditation (CGCRE), under the PMR 0009 number. The assessment of this conformity is carried out according to the requirements established in ABNT NBR standards ISO 17034 and Inmetro, thus ensuring competence for the production of MRCs, according to the Scope of Accreditation.

CAL 0214

Accreditation Cgcre/Inmetro - Calibration Laboratory

In December 2002, the Calibration Laboratory was accredited by Inmetro’s General Coordination for Accreditation (CGCRE). With this recognition, it became an integral part of the Brazilian network of accredited laboratories, under nº214. Since then, it is periodically evaluated for the maintenance and/or extension of accreditation.

PEP 0003

Accreditation Cgcre/Inmetro - Control Laboratory

In September 2011, Controllab was accredited by Inmetro’s General Coordination for Accreditation (CGCRE) as a proficiency test provider, under nº PEP0003. Initially as part of a pilot project by Inmetro, this accreditation was based on ILAC G13: 2007 and included several clinical and hemotherapy tests. In the periodic evaluations of this accreditation, new segments and tests are included and the evaluation is now conducted according to ABNT NBR ISO/IEC 17043.

This accreditation attests to Controllab’s technical competence to develop and conduct proficiency tests in accordance with international requirements and enables it to be recognized in other countries, in accordance with mutual recognition agreements signed by Brazil in Mercosur, the Americas and Europe.